Omalizumab improves efficacy of oral immunotherapy for multiple food allergies – EurekAlert (press release)
Scope |
Omalizumab improves efficacy of oral immunotherapy for multiple food allergies
EurekAlert (press release) Combining a 16-week initial course of the medication omalizumab with oral immunotherapy (OIT) greatly improves the efficacy of OIT for children with allergies to multiple foods, new clinical trial findings show. After 36 weeks, more than 80 percent of … Combo Tx Promising in Kids with Multi-Food Allergies Drug increases speed, safety of treatment for multiple food allergies |
